Roche subsidiary Genentech has picked up its option to purchase a biologics manufacturing plant from Lonza. The facility will be merged with Genentech's existing facility in Singapore. Lonza will receive $290m and up to $70m in milestone payments.
In-pharma Technologist
Wednesday, 2 September 2009
Lonza sells Singapore plant to Roche
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment